Summary of clinical experience with recombinant factor VIII products--Recombinate.
White
G C
GC
Department of Medicine, University of North Carolina, Chapel Hill 27599-7035.
D016063:Blood Loss, Surgical / Q000517:prevention & control; D005169:Factor VIII / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity*; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D012189:Retrospective Studies
D011994:Recombinant Proteins; C078147:F8 protein, human; D005169:Factor VIII